Rocket One Inc. Lessee, Operating Lease, Liability, to be Paid, Year One
Rocket One Inc. (RKTO) had Lessee, Operating Lease, Liability, to be Paid, Year One of $5.75 thousand as of 2025-12-31, per its 10-K filed 2026-03-27.
Financial Statements › Notes › Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity
us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths · last filed 2026-03-27
- 2025-12-31: Lessee, Operating Lease, Liability, to be Paid, Year One $5.75K.
- 2025-09-30: Lessee, Operating Lease, Liability, to be Paid, Year One $5.75K.
- 2025-06-30: Lessee, Operating Lease, Liability, to be Paid, Year One $5.75K.
- 2025-03-31: Lessee, Operating Lease, Liability, to be Paid, Year One $5.75K.
| Period end | Lessee, Operating Lease, Liability, to be Paid, Year One |
|---|---|
| 2025-12-31 | $5.75K 10-K · filed 2026-03-27 |
| 2025-09-30 | $5.75K 10-Q · filed 2025-11-12 |
| 2025-06-30 | $5.75K 10-Q · filed 2025-08-12 |
| 2025-03-31 | $5.75K 10-Q · filed 2025-05-12 |
| 2024-12-31 | $30.05K 10-K · filed 2025-03-28 |
| 2024-09-30 | $32.78K 10-Q · filed 2024-11-12 |
| 2024-06-30 | $32.78K 10-Q · filed 2024-08-09 |
| 2024-03-31 | $32.78K 10-Q · filed 2024-05-14 |
| 2023-12-31 | $32.78K 10-K · filed 2024-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |